Moffitt Receives More Than $2 Million in Florida Grants

January 09, 2007

Tampa, FL – Several researchers at H. Lee Moffitt Cancer Center & Research Institute will receive $2.2 million in funding from the Bankhead Coley Cancer Research Program, more than any other Florida university or research institute. The grants provide interim support for promising cancer-related research projects that have been highly rated in recent National Institutes of Health peer-reviewed competitions, (including the National Cancer Institute) but have not been funded due to federal budgetary constraints.  

Moffitt investigators were awarded two of the seven grants for shared equipment:

  • John Koomen, Ph.D.

      A hybrid quadruple ion trap mass spectrometer for the Proteomics Core facility


  • Dr. Timothy Yeatman

      An automated tissue storage system for the Tissue Core facility


  • Lori Hazelhurst, Ph.D. was one of three new investigators state-wide who received two years of funding for her work in hematopoietic tumor research.


Other one-year awards went to:

  • Srikumar Chellappan, Ph.D.

      Non-small cell lung cancer research


  • Jiandong Chen, Ph.D.

      Function and regulation of SirT1 in cancer


  • Dr. Dmitry Gabrilovich, Ph.D.

      Notch signaling in chemotherapy of multiple myeloma


  • Dr. David Shibata

      Tumor suppression


  • Jie Wu, Ph.D.

      New cancer therapeutics and tools for chemical biology


Other Moffitt members based at the University of South Florida also received funding for one year:

  • Wenlong Bai, Ph.D.

      Ovarian cancer research


  • George Blank, Ph.D.

      Negative regulation of the MHC class II promoters


  • Richard Heller, Ph.D.

      Therapeutic potential of plasmid delivery to tumors using electroporation


  • Shyam Mohapatra, Ph.D.

      Nanoparticle research for lung cancer



About H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida on the University of South Florida campus, H. Lee Moffitt Cancer Center & Research Institute ( is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 16 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.